Therapeutic potential of the Nox1/4 inhibitor GKT137831 in scleroderma

被引：0
|
作者：
Dosoki, H. [1 ,2 ]
Taha, M. [3 ]
Schnittler, H. [3 ]
Szyndralewiez, C. [4 ]
Luger, T. A. [1 ]
Boehm, M. [1 ]
机构：
[1] Univ Munster, Dept Dermatol, Munster, Germany
[2] Univ Alexandria, Dept Bot & Microbiol, Alexandria, Egypt
[3] Univ Munster, Dept Anat, Munster, Germany
[4] Genkyotex SA, Geneva, Switzerland
来源：
EXPERIMENTAL DERMATOLOGY | 2017年 / 26卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
P084
引用
收藏
页码：E36 / E36
页数：1
相关论文
共 50 条
  • [21] Evaluating the efficacy and safety of GKT137831 in adults with type 1 diabetes and persistently elevated urinary albumin excretion: a statistical analysis plan
    Alysha M. De Livera
    Anne Reutens
    Mark Cooper
    Merlin Thomas
    Karin Jandeleit-Dahm
    Jonathan E. Shaw
    Agus Salim
    Trials, 21
  • [22] Early oxidative damage induced by doxorubicin: Source of production, protection by GKT137831 and effect on Ca2+ transporters in HL-1 cardiomyocytes
    Asensio-Lopez, Mari C.
    Soler, Fernando
    Sanchez-Mas, Jesus
    Pascual-Figal, Domingo
    Fernandez-Belda, Francisco
    Lax, Antonio
    ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 2016, 594 : 26 - 36
  • [23] NOX4抑制剂GKT137831诱导肺鳞癌H226细胞凋亡及增强紫杉醇敏感性的研究
    宋少飞
    刘冰
    广东药科大学学报, 2021, 37 (04) : 22 - 27
  • [24] Nox4 Inhibition, by GKT 137831, Decreases Obesity-Associated Vascular Dysfunction and Pro-Fibrotic Effects
    Montezano, Augusto C.
    Cat, Aurelie Nguyen Dinh
    Even, Sarah E.
    Antunes, Tayze
    Briet, Marie
    He, Ying
    Callera, Glaucia E.
    McCulloch, Jim
    Carswell, Andrew
    Jandeleit-Dahm, Karin
    Cooper, Mark E.
    Szyndralewiez, Cedric
    Page, Patrick
    Touyz, Rhian M.
    HYPERTENSION, 2013, 62 (03)
  • [25] Expression of NOX1 and NOX4 in neuronal apoptosis
    Hilburger, E
    Begdache, L
    Tammariello, S
    FREE RADICAL BIOLOGY AND MEDICINE, 2004, 37 : S128 - S128
  • [26] THE NOX1/4 INHIBITOR GKT831 ACHIEVES CLINICALLY MEANINGFUL REDUCTIONS IN LIVER STIFFNESS, ATTENUATES CHOLESTASIS, AND IMPROVES QUALITY OF LIFE IN PATIENTS WITH PRIMARY BILIARY CHOLANGITIS
    Huang, Jonathan C.
    Invernizzi, Pietro
    Dalekos, George N.
    Nevens, Frederik
    Van Vlierberghe, Hans
    Zigmond, Ehud
    Andrade, Raul J.
    Ben-Ari, Ziv
    Heneghan, Michael A.
    Harrison, Stephen A.
    Minuk, Gerald Y.
    Schattenberg, Joern
    Moreno, Christophe
    Vierling, John M.
    Vincent, Catherine
    Bowlus, Christopher L.
    Lurie, Yoav
    Muratori, Luigi
    Niro, Grazia
    Hirschfield, Gideon
    Post, Anthony B.
    Zeuzen, Stefan
    Welzel, Tania
    Ch'Ng, Chinlye
    Levy, Cynthia
    Miller, Michael H.
    Collier, Jane D.
    Corless, Lynsey
    Dieterich, Douglas T.
    Kremer, Andreas
    Papatheodoridis, George V.
    Romeo, David P.
    Silveira, Marina G.
    Bernstein, David Eric
    Naftaly-Cohen, Michal
    Floreani, Annarosa
    Borg, Brian
    Carey, Elizabeth J.
    Hollywood, Coral
    Maliakkal, Benedict J.
    Marzioni, Marco
    Rabinovitz, Mordechai
    Rupp, Christian
    Sheridan, David A.
    Stanca, Carmen M.
    Swain, Mark Gordon
    Veitsman, Ella
    Ntourakis, Spyridon P.
    Wiesel, Philippe
    HEPATOLOGY, 2019, 70 : 777A - 779A
  • [27] Nox1 as a Therapeutic Target to Improve Survival in Influenza a Infection
    Hofstetter, Amelia Ruth
    De La Cruz, Juan A.
    Patel, Jenish R.
    McCoy, James W.
    Cao, Weiping
    Kim, Jin H.
    Diebold, Becky A.
    Belser, Jessica A.
    Tumpey, Terrence M.
    Katz, Jacqueline M.
    Sambhara, Suryaprakash
    Gangappa, Shivaprakash
    Lambeth, J. David
    FREE RADICAL BIOLOGY AND MEDICINE, 2013, 65 : S125 - S125
  • [28] The Nox1/Nox4 inhibitor attenuates acute lung injury induced by ischemia-reperfusion in mice
    Cui, Yu
    Wang, Yu
    Li, Gen
    Ma, Wan
    Zhou, Xiao-shuang
    Wang, Jia
    Liu, Bin
    PLOS ONE, 2018, 13 (12):
  • [29] Renoprotective effects of a novel Nox1/4 inhibitor in a mouse model of Type 2 diabetes
    Sedeek, Mona
    Gutsol, Alex
    Montezano, Augusto C.
    Burger, Dylan
    Aurelie Nguyen Dinh Cat
    Kennedy, Chris R. J.
    Burns, Kevin D.
    Cooper, Mark E.
    Jandeleit-Dahm, Karin
    Page, Patrick
    Szyndralewiez, Cedric
    Heitz, Freddy
    Hebert, Richard L.
    Touyz, Rhian M.
    CLINICAL SCIENCE, 2013, 124 (3-4) : 191 - 202
  • [30] Targeting NADPH oxidase with a novel dual Nox1/Nox4 inhibitor attenuates renal pathology in type 1 diabetes
    Gorin, Yves
    Cavaglieri, Rita C.
    Khazim, Khaled
    Lee, Doug-Yoon
    Bruno, Francesca
    Thakur, Sachin
    Fanti, Paolo
    Szyndralewiez, Cedric
    Barnes, Jeffrey L.
    Block, Karen
    Abboud, Hanna E.
    AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 2015, 308 (11) : F1276 - F1287
12345